Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 All-oral HCV therapies near approval.

× No keyword cloud information.

7 in total

1. 2014 FDA drug approvals.

Authors: Asher Mullard
Journal: Nat Rev Drug Discov Date: 2015-02 Impact factor: 84.694

2. Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.

Authors: Erika Piccirillo; Benjamin Merget; Christoph A Sotriffer; Antonia T do Amaral
Journal: J Comput Aided Mol Des Date: 2016-02-29 Impact factor: 3.686

Review 3. Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors: Lynn B Dustin
Journal: Curr Drug Targets Date: 2017 Impact factor: 3.465

Review 4. Immune control and failure in HCV infection--tipping the balance.

Authors: Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal: J Leukoc Biol Date: 2014-07-11 Impact factor: 4.962

5. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

Authors: Amaravadhi Harikishore; Enlin Li; Jia Jun Lee; Nam-Joon Cho; Ho Sup Yoon
Journal: Mol Divers Date: 2015-04-11 Impact factor: 2.943

6. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.

Authors: Anne Frentzen; Engin Gürlevik; Qinggong Yuan; Eike Steinmann; Michael Ott; Peter Staeheli; Jonathan Schmid-Burgk; Tobias Schmidt; Veit Hornung; Florian Kuehnel; Thomas Pietschmann
Journal: J Virol Date: 2015-01-21 Impact factor: 5.103

Review 7. The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.

Authors: Siobhán B Cashman; Brian D Marsden; Lynn B Dustin
Journal: Front Immunol Date: 2014-11-10 Impact factor: 7.561

7 in total